shubhmita bhatnagar
Temple University
Philadelphia, United States
Review Editor
Technologies and Strategies to Enable Drug Discovery
Temple University
Philadelphia, United States
Review Editor
Technologies and Strategies to Enable Drug Discovery
Spanish National Cancer Research Center
Madrid, Spain
Review Editor
Anti-Cancer Drugs
Tufts Medical Center
Boston, United States
Review Editor
Cardiovascular and Hematologic Drugs
University of California, Santa Cruz
Santa Cruz, United States
Review Editor
In silico Methods and Artificial Intelligence for Drug Discovery
Federal University of Pará
Belém, Brazil
Review Editor
Anti-Infective Agents
Department of Chemistry and Pharmaceutical Technologies, Faculty of Pharmacy and Medicine, Sapienza University of Rome
Rome, Italy
Review Editor
Anti-Infective Agents
School of Pharmacy, Federal University of Ouro Preto
Ouro Preto, Brazil
Review Editor
Technologies and Strategies to Enable Drug Discovery
Helmholtz-Institute for Pharmaceutical Research Saarland (HIPS)
Saarbrücken, Germany
Review Editor
In silico Methods and Artificial Intelligence for Drug Discovery
National Autonomous University of Mexico
México City, Mexico
Review Editor
Anti-Cancer Drugs
Oswaldo Cruz Foundation (Fiocruz)
Rio de Janeiro, Brazil
Review Editor
Anti-Infective Agents
Institute of Oncology, Dokuz Eylül University
Izmir, Türkiye
Review Editor
Anti-Cancer Drugs
São Carlos Institute of Physics, University of São Paulo
São Carlos, Brazil
Review Editor
Anti-Infective Agents
University of São Paulo
São Paulo, Brazil
Review Editor
Anti-Infective Agents
Mercer University
Atlanta, United States
Review Editor
Neurological Drugs
North Carolina State University
Raleigh, United States
Review Editor
In silico Methods and Artificial Intelligence for Drug Discovery
Department of Chemistry, Faculty of Philosophy, Sciences and Languages of Ribeirão Preto, University of São Paulo
Ribeirão Preto, Brazil
Review Editor
Anti-Infective Agents